Single and Multiple Ascending Dose Study of AMG 133 in Participants With Obesity
NCT04478708
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
110
Enrollment
INDUSTRY
Sponsor class
Conditions
Obesity
Interventions
BIOLOGICAL:
maridebart cafraglutide
DRUG:
Placebo
Sponsor
Amgen